[DPHARMA] Change In Substantial Shareholder's Shareholding - EMPLOYEES PROVIDENT FUND BOARD on 18-Sep-2024

Announcement Date
18-Sep-2024
Director's Particular:
Details of Changes:
Currency
-
Date of ChangeTypeNumber of Shares
12-Sep-2024Acquired17,900
Registered Name
Citigroup Nominees (Tempatan) Sdn. Bhd.
Nature of Interest
Direct Interest
Nature Interest
Indirect Interest
Shares
Ordinary Shares
Reason
Acquisition of 17,900 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (KIB-ESG-EQ)
Total no of securities after change:
Direct (units)
0
Direct (%)
0.00
Indirect (units)
85,621,774
Indirect (%)
8.90
Total (units)
85,621,774
Total (%)
8.90
Date of Notice
13-Sep-2024
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment